merck

The findings published in the journal Nature suggests that molnupiravir may enable mutated viruses to spread.

The five largest pharmaceutical companies in the United States netted approximately $81.9 billion last year, according to a ...

Janssen, the pharmaceutical arm of Johnson & Johnson, filed a lawsuit against the U.S. government on Tuesday, joining ...

Pharmaceutical company Merck & Co. Inc. is facing lawsuits that accuse the firm of downplaying potential negative psychiatric ...

Merck & Co. filed a lawsuit against the U.S. government on June 6, saying that Medicare's new program, ...

California just passed a health bill that aims to increase vaccination rates in schools and colleges against a ...

The phase 3 clinical trial of Merck’s COVID-19 antiviral molnupiravir, branded as Lagevrio, has ended up in failure, ...

A widely used COVID-19 treatment drug could be linked to mutations that create new variants of the disease, ...

Merck & Co. Inc. opted to jointly develop and potentially sell a personalized mRNA vaccine with Moderna Inc. ...

Singapore has approved a second oral antiviral drug for treating COVID-19. Molnupiravir, branded as Lagevrio, was granted interim ...

Merck & Co. on Thursday reported quarterly profit and sales that beat estimates and raised its full-year forecasts ...

The U.S. Food and Drug Administration has declined to approve a lung cancer drug U.S. drugmaker Eli Lilly ...

Merck & Co said on Wednesday it expects its 2022 sales to increase as much as 18 percent ...

The European Commission (EC) on Friday authorized the use of Pfizer's COVID-19 antiviral pill one day after the ...

Researchers and U.S. health regulators are concerned that the CCP (Chinese Communist Party) virus may quickly develop resistance to ...

Merck's COVID-19 oral pill molnupiravir has a mechanism of action that can work against Omicron and any other ...

MILAN—Italy will receive around 40,000 doses of Merck & Co.'s COVID-19 antiviral drug next week, which will add ...

After several months of legal back-and-forth in the courtroom, with the FDA requesting up to 75 years to ...

India's top health research body announced on Wednesday that it won’t be adding Merck’s COVID-19 antiviral pill molnupiravir to its ...

Indian multinational pharmaceutical company Dr. Reddy’s Laboratories will be launching a generic version of Merck's COVID-19 oral antiviral ...

PARIS—France has canceled its order for Merck & Co.'s COVID-19 antiviral drug following disappointing trial data and hopes ...

The Food and Drug Administration (FDA) on Thursday morning issued an emergency use authorization for Merck's antiviral pill for ...

Denmark on Dec. 16 approved an antiviral COVID-19 drug produced by Merck and Ridgeback Biotherapeutics for at-risk patients ...

Outside advisers to the U.S. Food and Drug Administration (FDA) on Tuesday narrowly voted to recommend the agency ...

A new analysis of clinical trial results shows that Merck’s antiviral pill for treating COVID-19 is significantly less ...

The European Union's drug regulator on Friday advised that an experimental COVID-19 pill from Merck should be given ...

Merck Inc. is locking horns with peer Pfizer Inc. in what could be termed as the battle supremacy ...